From world-class science to patient-centered care, the 2022 ASCO Genitourinary (GU) Cancers Symposium offered new, innovative findings in the study, diagnosis, and treatment of GU malignancies.   Catch up on key trials in prostate, bladder and kidney cancer, including findings from the PROpel, ARASENS, and BAYOU studies and more.
View all videos

GU Cancers 2022

ASCO Genitourinary Cancers Symposium
17–19 February 2022 | San Francisco, CA

🚨 #TTLC24 is only 24 hours away, and if you follow the latest updates in targeted therapies for #lungcancer, check out http://VJOncology.com for exclusive interviews with leading experts! 💻

@VJOncology @IASLC #LCSM #NSCLC #SCLC

🎥@maughanonc from @UUtah highlights #GU24, discussing BRCAAway and CONTACT-2 trials in mCRPC. Insights on cabozantinib, atezolizumab, and pembrolizumab in bladder cancer, evaluating their role alongside enfortumab vedotin:

➡️⬅️

#Blcsm #ImmunoOnc #CTSM

Image for twitter card

ASCO GU 2024 highlights: BRCAAway, CONTACT-2 and KEYNOTE-564

Benjamin Maughan, MD, PharmD, University of Utah, Salt Lake City, UT, provides his highlights from the ASCO GU Can...

ow.ly

Load More

GU Cancers 2022

ASCO Genitourinary Cancers Symposium
17–19 February 2022 | San Francisco, CA
From world-class science to patient-centered care, the 2022 ASCO Genitourinary (GU) Cancers Symposium offered new, innovative findings in the study, diagnosis, and treatment of GU malignancies.   Catch up on key trials in prostate, bladder and kidney cancer, including findings from the PROpel, ARASENS, and BAYOU studies and more.
View all videos

🚨 #TTLC24 is only 24 hours away, and if you follow the latest updates in targeted therapies for #lungcancer, check out http://VJOncology.com for exclusive interviews with leading experts! 💻

@VJOncology @IASLC #LCSM #NSCLC #SCLC

🎥@maughanonc from @UUtah highlights #GU24, discussing BRCAAway and CONTACT-2 trials in mCRPC. Insights on cabozantinib, atezolizumab, and pembrolizumab in bladder cancer, evaluating their role alongside enfortumab vedotin:

➡️⬅️

#Blcsm #ImmunoOnc #CTSM

Image for twitter card

ASCO GU 2024 highlights: BRCAAway, CONTACT-2 and KEYNOTE-564

Benjamin Maughan, MD, PharmD, University of Utah, Salt Lake City, UT, provides his highlights from the ASCO GU Can...

ow.ly

Load More